Jonathan S. Rink

Biomimetic, synthetic HDL nanostructures for lymphoma

Shuo Yang, Marina G. Damiano, Heng Zhang et al. · Proceedings of the National Academy of Sciences · 2013 · 127 citations · Full text

Nanoparticles, Nanomedicine, Nanotherapeutics +15

Nitric Oxide-Delivering High-Density Lipoprotein-like Nanoparticles as a Biomimetic Nanotherapy for Vascular Diseases

Jonathan S. Rink, Wangqiang Sun, Sol Misener et al. · ACS Applied Materials & Interfaces · 2018 · 55 citations · Full text

Nanoparticles, Nanotherapeutics, Vascular Diseases +17

High-Density Lipoprotein-like Magnetic Nanostructures (HDL-MNS): Theranostic Agents for Cardiovascular Disease

Vikas Nandwana, Soo‐Ryoon Ryoo, Shanthi Kanthala et al. · Chemistry of Materials · 2017 · 53 citations

Nanoparticles, Nanotherapeutics, Engineering +24

Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis

Jonathan S. Rink, Adam Yuh Lin, Kaylin M. McMahon et al. · Journal of Biological Chemistry · 2020 · 51 citations · Full text

Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin

Jonathan S. Rink, Shuo Yang, Osman Çen et al. · Molecular Pharmaceutics · 2017 · 44 citations · Full text

Abc Dlbcl, Immunology, Cellular Cholesterol +18